[
  {
    "question": "What is subclinical hypothyroidism (SCH)?",
    "answer": "Subclinical hypothyroidism (SCH) is defined as a condition where the thyroid-stimulating hormone (TSH) level is greater than the upper limit of the normal range (4.5–5.0 mIU/L) while free thyroxine (FT4) levels remain normal.",
    "is_verified": 1
  },
  {
    "question": "What are the potential risks associated with untreated subclinical hypothyroidism in infertile women?",
    "answer": "Untreated subclinical hypothyroidism can lead to infertility, miscarriage, and adverse obstetrical and neurodevelopmental outcomes in offspring.",
    "is_verified": 1
  },
  {
    "question": "What is the incidence of subclinical hypothyroidism in the reproductive-age population?",
    "answer": "The incidence of subclinical hypothyroidism in the reproductive-age population is approximately 4%–8%.",
    "is_verified": 1
  },
  {
    "question": "What complications can overt hypothyroidism cause in reproductive outcomes?",
    "answer": "Overt hypothyroidism can lead to an increased incidence of infertility, miscarriage, and adverse obstetric, fetal, and neurocognitive development outcomes in offspring.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of thyroid-stimulating hormone (TSH) in the context of subclinical hypothyroidism?",
    "answer": "Thyroid-stimulating hormone (TSH) is crucial for diagnosing subclinical hypothyroidism, as elevated TSH levels indicate potential thyroid dysfunction while FT4 levels remain normal.",
    "is_verified": 1
  },
  {
    "question": "What is the impact of inadequate thyroid function on fertility and pregnancy?",
    "answer": "Inadequate thyroid function, particularly subclinical hypothyroidism (SCH), can affect fertility and pregnancy outcomes. The current understanding is based on mainly retrospective studies, indicating that thyroid dysfunction and thyroid autoimmunity (TAI) may have negative implications for these outcomes. However, the literature is limited and of varying quality, making it challenging to draw definitive conclusions.",
    "is_verified": 1
  },
  {
    "question": "What are the treatment recommendations for subclinical hypothyroidism (SCH)?",
    "answer": "Treatment recommendations for SCH vary among several medical organizations, including the American Society for Reproductive Medicine (ASRM), the Endocrine Society, the American Thyroid Association (ATA), and others. These guidelines are informed by the existing literature, which, despite being limited in high-quality data, shows consistent trends regarding the treatment of SCH and its effects on fertility and pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What challenges exist in interpreting the literature on SCH and fertility outcomes?",
    "answer": "Challenges in interpreting the literature on SCH and fertility outcomes include the use of varying TSH levels to define SCH across studies, which complicates comparisons. Most studies are of low to intermediate quality and are at risk for bias, with very few randomized trials available. Additionally, many studies are underpowered, leading to potential type I and type II errors, and there is significant heterogeneity in the populations sampled.",
    "is_verified": 1
  },
  {
    "question": "What organization supported the publication of the book excerpt?",
    "answer": "The American Society for Reproductive Medicine (ASRM) supported the publication.",
    "is_verified": 1
  },
  {
    "question": "What is the focus of the ASRM Practice Committee mentioned in the excerpt?",
    "answer": "The ASRM Practice Committee focuses on developing guidelines related to reproductive medicine.",
    "is_verified": 1
  },
  {
    "question": "What type of funding does the ASRM receive for the development of guidelines?",
    "answer": "The ASRM receives no outside funding for the development of guidelines.",
    "is_verified": 1
  },
  {
    "question": "What is SCH and how is it related to reproductive outcomes?",
    "answer": "SCH stands for Subclinical Hypothyroidism. It is associated with miscarriage, infertility, adverse obstetric outcomes, and neurodevelopmental outcomes in offspring. The guideline provides evidence-based recommendations for defining SCH and its implications on reproductive health.",
    "is_verified": 1
  },
  {
    "question": "What are the treatment recommendations for SCH?",
    "answer": "The guideline discusses treatment of SCH aimed at improving miscarriage rates, clinical pregnancy, live birth outcomes, and neurodevelopmental outcomes in offspring.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of antithyroid antibodies in relation to reproductive health?",
    "answer": "The guideline mentions the association of antithyroid antibodies with adverse reproductive outcomes, indicating their potential impact on fertility and pregnancy success.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of elevated TSH levels during pregnancy?",
    "answer": "Elevated TSH (Thyroid Stimulating Hormone) levels during pregnancy can indicate subclinical hypothyroidism, which is associated with various complications such as pregnancy loss, miscarriage, and preeclampsia. Monitoring and managing thyroid levels is crucial for maintaining a healthy pregnancy and improving live-birth rates.",
    "is_verified": 1
  },
  {
    "question": "What types of studies were included in the literature search for the guideline on pregnancy and thyroid health?",
    "answer": "The literature search included randomized controlled trials (RCTs), systematic reviews or meta-analyses of RCTs, controlled trials without randomization, cohort studies, and case-control studies. Descriptive studies, case series, case reports, and nonsystematic reviews were excluded.",
    "is_verified": 1
  },
  {
    "question": "What are the potential outcomes of untreated subclinical hypothyroidism in pregnant women?",
    "answer": "Untreated subclinical hypothyroidism in pregnant women can lead to adverse outcomes such as increased risk of miscarriage, preeclampsia, and other pregnancy complications, potentially affecting both maternal and fetal health.",
    "is_verified": 1
  },
  {
    "question": "What was the time frame for the literature search conducted for the guideline?",
    "answer": "The literature search was restricted to human subject research published in the English language from April 2014 to February 2020, with updates made on August 24, 2022.",
    "is_verified": 1
  },
  {
    "question": "What outcomes were identified by the task force in the evidence table?",
    "answer": "The outcomes identified by the task force included LB (likely referring to live birth), clinical pregnancy, miscarriage, and obstetric as well as neonatal adverse outcomes.",
    "is_verified": 1
  },
  {
    "question": "What factors were assessed to evaluate the quality of the studies?",
    "answer": "The quality of the studies was assessed based on components including blinding, allocation concealment, appropriate control groups, intention-to-treat analysis, generalizability, and risk of bias.",
    "is_verified": 1
  },
  {
    "question": "What role did the consulting epidemiologist play in the assessment of study quality?",
    "answer": "The consulting epidemiologist confirmed agreement with the expert task force’s assessment of quality based on the strengths and limitations of the studies.",
    "is_verified": 1
  },
  {
    "question": "What is the purpose of the evidence-based recommendations mentioned in the excerpt?",
    "answer": "The purpose of the evidence-based recommendations is to optimize patient care and help guide medical practice in the field of reproductive medicine, specifically for women with SCH (subchorionic hemorrhage).",
    "is_verified": 1
  },
  {
    "question": "What factors were considered in determining the strengths of the recommendations in the guideline?",
    "answer": "The strengths of the recommendations were based on the quality and strength (confidence/certainty) of evidence, risks, benefits, and expert judgment of the Practice Committee and task force.",
    "is_verified": 1
  },
  {
    "question": "What is the definition of subclinical hypothyroidism (SCH) in nonpregnant women?",
    "answer": "Subclinical hypothyroidism is diagnosed as a TSH concentration above the upper limit of the normal range and a serum-free thyroxine (T4) concentration within the normal range. This designation applies when thyroid function has been stable for weeks, the hypothalamic-pituitary-thyroid axis is normal, and there is no recent or ongoing severe illness.",
    "is_verified": 1
  },
  {
    "question": "What is the upper limit of normal for TSH in nonpregnant patients living in iodine-sufficient areas?",
    "answer": "An upper limit of normal of 4.12 mIU/L should be used for patients who live in an iodine-sufficient area, based on the upper normal TSH limit for a studied reference population that was not pregnant and did not have laboratory evidence of hyperthyroidism or hypothyroidism.",
    "is_verified": 1
  },
  {
    "question": "What are the pooled prevalence rates for hypothyroidism?",
    "answer": "Pooled prevalence rates calculated from studies using the 97.5th percentile as an upper limit for TSH were 0.50% for overt hypothyroidism, 3.47% for subclinical hypothyroidism (SCH), and 2.05% for isolated hypothyroxinemia.",
    "is_verified": 1
  },
  {
    "question": "How do TSH levels vary during pregnancy?",
    "answer": "There is known variability in TSH levels during pregnancy, with a typical decrease in TSH levels during the first trimester, attributed to the weak thyroid stimulatory effect of human chorionic gonadotropin.",
    "is_verified": 1
  },
  {
    "question": "What are the recommended thyroid function tests during pregnancy?",
    "answer": "Both TSH and serum total T4 levels should be obtained. However, immunoassays of free T4 in pregnancy may be altered by changes in serum proteins and are thus not recommended.",
    "is_verified": 1
  },
  {
    "question": "How does the upper limit of TSH in pregnancy vary?",
    "answer": "The upper limit of TSH in pregnancy depends on the trimester. It can be reduced by 0.5 mIU/L in the first trimester and should use nonpregnant thresholds later in pregnancy if local laboratory pregnancy cutoffs are unavailable.",
    "is_verified": 1
  },
  {
    "question": "Is universal screening of thyroid function recommended for women attempting pregnancy?",
    "answer": "No, universal screening of thyroid function is not recommended for patients who are attempting pregnancy, including those undergoing assisted reproduction.",
    "is_verified": 1
  },
  {
    "question": "What are the indications for thyroid testing in women attempting pregnancy?",
    "answer": "Indications for thyroid testing include increased risk of overt hypothyroidism, such as having autoimmune disease, psychiatric disorder, family history of thyroid disease, history of neck radiation, prior thyroid dysfunction or surgery, signs or symptoms of thyroid dysfunction, or palpable thyroid abnormalities on examination.",
    "is_verified": 1
  },
  {
    "question": "What should be used for TSH levels in women attempting pregnancy?",
    "answer": "The defined age-based cutoffs for nonpregnant patients should be used until pregnancy is achieved, as there is insufficient evidence that pregnancy thresholds for TSH levels should be applied for women attempting pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the moderate evidence regarding TSH assay reference ranges?",
    "answer": "There is moderate evidence that the reference range of a given laboratory should determine the upper limit of normal for a third-generation TSH assay for pregnant and nonpregnant patients.",
    "is_verified": 1
  },
  {
    "question": "What are the defined upper limits of normal TSH levels?",
    "answer": "The upper limit of normal TSH levels is 4.12 mIU/L for nonpregnant patients and those attempting pregnancy; it should be reduced by 0.5 mIU/L for pregnant patients in the first trimester, and nonpregnant thresholds should be used in the first and third trimesters.",
    "is_verified": 1
  },
  {
    "question": "What are the inclusion criteria for the studies mentioned in the excerpt?",
    "answer": "The inclusion criteria for the studies mentioned are: randomized controlled trials (RCTs), systematic reviews or meta-analyses of RCTs, systematic reviews or meta-analyses of a combination of RCTs, controlled trials without randomization, cohort studies, and studies with a comparison group, including placebo or no treatment.",
    "is_verified": 1
  },
  {
    "question": "What are the exclusion criteria for the studies mentioned in the excerpt?",
    "answer": "The exclusion criteria for the studies mentioned are: descriptive studies, case series, case reports, letters, nonsystematic reviews, opinions based on clinical experience, reports of expert committees, abstracts, animal studies, studies without a comparison group, and non-English studies.",
    "is_verified": 1
  },
  {
    "question": "What outcomes are considered in the studies related to subclinical hypothyroidism and infertility?",
    "answer": "The outcomes considered in the studies related to subclinical hypothyroidism and infertility include live birth, clinical pregnancy, miscarriage, obstetric, and neonatal adverse events.",
    "is_verified": 1
  },
  {
    "question": "What specific patient population is mentioned in relation to subclinical hypothyroidism?",
    "answer": "The specific patient populations mentioned in relation to subclinical hypothyroidism are patients with subclinical hypothyroidism and infertility, as well as patients with subclinical hypothyroidism in the first trimester of pregnancy.",
    "is_verified": 1
  },
  {
    "question": "Which medical practice committee is referenced in the excerpt?",
    "answer": "The medical practice committee referenced in the excerpt is the Practice Committee of the American Society for Reproductive Medicine, specifically regarding subclinical hypothyroidism and infertility.",
    "is_verified": 1
  },
  {
    "question": "What are the recommended TSH cutoffs for diagnosing subclinical hypothyroidism (SCH) in nonpregnant and pregnant patients?",
    "answer": "Laboratory-specific TSH cutoffs should be used to diagnose SCH for both nonpregnant patients and pregnant patients by trimester. If laboratory cutoffs are not available, defined upper limits of normal TSH levels should be utilized.",
    "is_verified": 1
  },
  {
    "question": "Is untreated subclinical hypothyroidism (SCH) associated with miscarriage?",
    "answer": "Yes, untreated SCH is associated with miscarriage. Studies have shown that pregnant patients with untreated SCH have a similar risk of first-trimester pregnancy loss compared to euthyroid women, with a relative risk (RR) of 1.38 (95% CI 0.65 – 2.96, P = .40).",
    "is_verified": 1
  },
  {
    "question": "What did the meta-analyses reveal about the relationship between SCH and pregnancy loss?",
    "answer": "Three meta-analyses were conducted to evaluate the association between SCH and pregnancy loss. One meta-analysis examined how SCH during pregnancy impacted outcomes, while another focused on the risk of pregnancy loss before 20 weeks. The findings indicated that untreated SCH does not significantly increase the risk of first-trimester pregnancy loss compared to euthyroid women.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between TSH levels and miscarriage risk in women?",
    "answer": "Data from almost 4,000 women showed no increased risk of miscarriage in women with TSH levels greater than 2.5 and 3.5 mIU/L. Specifically, a prospective cohort study involving over 1,200 women with unassisted pregnancies indicated that those with TSH levels of 2.5 mIU/L or higher did not have an increased risk of first-trimester pregnancy loss, with a relative risk of 1.07 (95% CI 0.81–1.41) compared to women with lower TSH levels.",
    "is_verified": 1
  },
  {
    "question": "What studies were included in the review regarding TSH levels and pregnancy loss?",
    "answer": "Five prospective studies were included in the review, with one being low-quality and four intermediate-quality studies. Three of these studies specifically focused on women with recurrent pregnancy loss (RPL).",
    "is_verified": 1
  },
  {
    "question": "What does the quality rating for evidence indicate in this context?",
    "answer": "The quality rating for evidence indicates the reliability of the studies reviewed. High-quality evidence is characterized by a clearly identified target population, sufficient sample size, clear study design, appropriate controls, generalizable results, definitive conclusions, minimal risk of bias, and is primarily based on well-designed systematic reviews or meta-analyses of randomized controlled trials. Intermediate quality evidence has similar characteristics but may benefit from larger studies and has reasonably consistent results with minimal risk of bias.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of the Practice Committee of the American Society for Reproductive Medicine in relation to SCH and infertility?",
    "answer": "The Practice Committee of the American Society for Reproductive Medicine provides guidelines and recommendations regarding the management of conditions such as Subclinical Hyperthyroidism (SCH) and its impact on infertility. Their publications, such as the one referenced in Fertility and Sterility, are crucial for informing practitioners about best practices and evidence-based approaches to treating infertility related to thyroid conditions.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between subclinical hypothyroidism (SCH) and pregnancy loss?",
    "answer": "Women with subclinical hypothyroidism (SCH) have a significantly higher risk of first-trimester pregnancy loss compared to euthyroid women, with a reported rate of 7.1% in the SCH group versus 2.2% in the euthyroid group. The adjusted odds ratio (aOR) for this increased risk is 3.40, indicating that SCH is associated with a greater likelihood of pregnancy loss.",
    "is_verified": 1
  },
  {
    "question": "What thyroid hormone levels were measured in the study of pregnant women?",
    "answer": "The study measured thyroid-stimulating hormone (TSH), free thyroxine (FT4), thyroid peroxidase antibodies (TPOAb), and thyroglobulin antibodies (TgAb) levels in pregnant women to assess thyroid dysfunction.",
    "is_verified": 1
  },
  {
    "question": "How does the definition of subclinical hypothyroidism (SCH) vary among studies?",
    "answer": "The definition of subclinical hypothyroidism (SCH) varies among studies, which can affect the analysis of data and outcomes related to pregnancy loss. This variation complicates the understanding of the relationship between SCH and reproductive outcomes.",
    "is_verified": 1
  },
  {
    "question": "What was the sample size and findings of the retrospective population-based cohort study regarding SCH and pregnancy loss?",
    "answer": "The retrospective population-based cohort study included over 180,000 women, with over 7,000 patients analyzed. It found that SCH was associated with a higher risk of pregnancy loss, with an adjusted odds ratio (aOR) of 1.15 compared to women with TSH levels less than 2.50 mIU/L.",
    "is_verified": 1
  },
  {
    "question": "What is the prevalence of subclinical hypothyroidism (SCH) in women undergoing IVF treatment at different TSH threshold levels?",
    "answer": "The prevalence of SCH was 5.1% when using a TSH threshold level of 4.0 mIU/L, but it increased to 29.9% when using a TSH threshold level of 2.5 mIU/L.",
    "is_verified": 1
  },
  {
    "question": "How does TSH level affect miscarriage rates in women with subclinical hypothyroidism during IVF treatment?",
    "answer": "Miscarriage rates were not different in women with SCH, regardless of whether the TSH threshold level was >2.5 or 4.0 mIU/L.",
    "is_verified": 1
  },
  {
    "question": "What were the findings of the retrospective cohort study regarding TSH levels and pregnancy outcomes in women undergoing IVF?",
    "answer": "The study found no differences in the rates of clinical pregnancy, delivery, or miscarriage among women with different TSH levels (2.5–4.5 mIU/L compared to <2.5 mIU/L).",
    "is_verified": 1
  },
  {
    "question": "What was the conclusion regarding early pregnancy loss and TSH levels in women undergoing IVF treatment?",
    "answer": "After adjusting for maternal age, early pregnancy loss was not associated with TSH level compared to euthyroid patients, with a P-value greater than 0.30.",
    "is_verified": 1
  },
  {
    "question": "Did maternal thyroid function from 11–13 weeks gestation impact pregnancy loss or fetal death?",
    "answer": "The excerpt mentions a study that evaluated maternal thyroid function during this period, but does not provide specific results regarding its impact on pregnancy loss or fetal death.",
    "is_verified": 1
  },
  {
    "question": "What is the association between FT4 levels and pregnancy loss?",
    "answer": "FT4 level was associated with pregnancy loss according to the logistic regression analysis in the study.",
    "is_verified": 1
  },
  {
    "question": "What does the evidence suggest about SCH during pregnancy and miscarriage risk?",
    "answer": "There is moderate evidence suggesting that subclinical hypothyroidism (SCH) during pregnancy is not associated with an increased risk of miscarriage, as most intermediate-quality studies do not show an increased risk.",
    "is_verified": 1
  },
  {
    "question": "What are the definitions of the strength of evidence ratings?",
    "answer": "Grade A indicates high confidence in the evidence, Grade B indicates moderate confidence, and Grade C indicates low confidence, with varying degrees of methodological quality and risk of bias in the studies reviewed.",
    "is_verified": 1
  },
  {
    "question": "What is the focus of the Practice Committee of the American Society for Reproductive Medicine in the provided excerpt?",
    "answer": "The focus is on SCH (Subclinical Hyperthyroidism) and its relationship with infertility, as indicated by the reference to a publication in Fertility and Sterility.",
    "is_verified": 1
  },
  {
    "question": "What is the association between TSH levels and miscarriage?",
    "answer": "TSH levels between 2.5 and 4.0 mIU/L are not associated with an increased risk of miscarriage, as recommended for counseling women.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation regarding subclinical hypothyroidism (SCH) and miscarriage?",
    "answer": "It is recommended to counsel women that subclinical hypothyroidism (SCH) is not associated with an increased risk of miscarriage, with a strength of evidence rated as B and a moderate strength of recommendation.",
    "is_verified": 1
  },
  {
    "question": "What studies have been conducted on SCH and infertility?",
    "answer": "Five retrospective studies evaluated the association between subclinical hypothyroidism (SCH) and infertility, with one study finding that SCH was diagnosed in 13.9% of women with infertility compared to 3.9% in the control group, suggesting a potential association.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding TSH levels in women with infertility?",
    "answer": "In a Finnish population cohort of infertile women, only 4% had abnormal TSH levels, which ranged from 5.7 to 32.0 mIU/L, and three of these women had been previously diagnosed with hypothyroidism.",
    "is_verified": 1
  },
  {
    "question": "How do TSH levels relate to different types of infertility?",
    "answer": "Thyroid-stimulating hormone levels were similar in women diagnosed with ovulatory dysfunction, unknown infertility, tubal factor infertility, and male infertility, indicating no significant differences based on TSH levels.",
    "is_verified": 1
  },
  {
    "question": "What was the outcome of the study comparing women undergoing intrauterine insemination with different TSH levels?",
    "answer": "The study found no difference in pregnancy outcomes between women with TSH levels of 2.5–4.5 mIU/L and those with TSH levels of less than 2.5 mIU/L.",
    "is_verified": 1
  },
  {
    "question": "What was the frequency of elevated TSH levels in women seeking infertility treatment?",
    "answer": "In a retrospective study of 704 women seeking treatment for infertility, 2.3% had elevated TSH levels, indicating that elevated TSH may be relatively uncommon in this population.",
    "is_verified": 1
  },
  {
    "question": "What is the treatment for abnormal TSH levels mentioned in the excerpt?",
    "answer": "The treatment for abnormal TSH levels mentioned in the excerpt is levothyroxine.",
    "is_verified": 1
  },
  {
    "question": "What is the association between subclinical hypothyroidism (SCH) and infertility according to the excerpt?",
    "answer": "The excerpt states that there is weak evidence that subclinical hypothyroidism (SCH) is not associated with an increased risk of infertility, and there is insufficient evidence to counsel women that SCH is associated with infertility.",
    "is_verified": 1
  },
  {
    "question": "What adverse obstetric outcomes may be associated with SCH or abnormal TSH levels during pregnancy?",
    "answer": "The excerpt mentions that there may be an increased risk for adverse obstetric outcomes among pregnant women with SCH or TSH levels outside of the normal range, including placental abruption, preterm birth, fetal death, and preterm premature rupture of membranes.",
    "is_verified": 1
  },
  {
    "question": "What types of studies were included in the guideline regarding SCH and obstetric outcomes?",
    "answer": "The guideline includes two systematic reviews, one randomized controlled trial (RCT), and 18 cohort studies that address the potential association between SCH and adverse obstetrical outcomes.",
    "is_verified": 1
  },
  {
    "question": "What is the quality of the literature regarding SCH and obstetric outcomes as mentioned in the excerpt?",
    "answer": "The bulk of the literature regarding SCH and obstetric outcomes is graded as low-quality, with some being intermediate-quality, and most studies were retrospective cohort studies.",
    "is_verified": 1
  },
  {
    "question": "What TSH levels are mentioned in the excerpt for defining subclinical hypothyroidism (SCH)?",
    "answer": "The excerpt mentions various threshold levels for defining subclinical hypothyroidism (SCH), including 3 mIU/L, >2.5 mIU/L, between 2.5 and 4.0 mIU/L, and the presence of antithyroid antibodies (TPOAb).",
    "is_verified": 1
  },
  {
    "question": "What is SCH and how is it defined in the studies mentioned?",
    "answer": "SCH stands for Subclinical Hypothyroidism, which is defined in the studies mentioned as having TSH levels greater than or equal to 2.5 mIU/L.",
    "is_verified": 1
  },
  {
    "question": "What treatment was evaluated in the randomized controlled trial (RCT) involving women with SCH?",
    "answer": "The treatment evaluated in the RCT was levothyroxine, compared to no treatment.",
    "is_verified": 1
  },
  {
    "question": "What were the primary and secondary outcomes measured in the study regarding levothyroxine treatment for SCH?",
    "answer": "The primary outcome measured was preterm delivery, and a secondary post hoc analysis suggested a reduction in preterm delivery with levothyroxine treatment.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding the risk of adverse pregnancy outcomes for women with SCH compared to euthyroid pregnant women?",
    "answer": "Pregnant women with SCH were found to be at higher risk for placental abruption, with a relative risk (RR) of 2.14 (95% CI 1.23 – 3.70) compared to euthyroid pregnant women.",
    "is_verified": 1
  },
  {
    "question": "What is the association between subclinical hypothyroidism (SCH) in early pregnancy and preeclampsia?",
    "answer": "Subclinical hypothyroidism (SCH) in early pregnancy is associated with an increased occurrence of preeclampsia, with an odds ratio (OR) of 1.7 (95% CI 1.1–2.6).",
    "is_verified": 1
  },
  {
    "question": "How does the presence of thyroid antibodies affect pregnancy outcomes in women with SCH?",
    "answer": "The presence of thyroid antibodies in women with subclinical hypothyroidism (SCH) is associated with an increased risk of preterm birth (OR 1.9, 95% CI 1.1–3.5) compared to the absence of thyroid antibodies. In contrast, SCH without thyroid antibodies is not likely to be associated with adverse obstetrical outcomes.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding preconception TSH levels and their association with adverse pregnancy outcomes?",
    "answer": "In a study evaluating preconception TSH levels, subclinical hypothyroidism (SCH) was not associated with preterm delivery, pregnancy loss, or large for gestational age births. However, it was associated with a slightly increased risk of small for gestational age infants (OR 1.16; 95% CI 1.01–1.33).",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between first trimester SCH diagnosis and pregnancy-induced hypertension?",
    "answer": "The first trimester diagnosis of subclinical hypothyroidism (SCH) is associated with pregnancy-induced hypertension and preeclampsia, indicating potential adverse outcomes in this context.",
    "is_verified": 1
  },
  {
    "question": "What are the risks associated with subclinical hypothyroidism (SCH) during pregnancy?",
    "answer": "Subclinical hypothyroidism (SCH) during pregnancy is associated with several risks including increased fetal distress, preterm delivery, poor vision in infants, fetal loss, neurodevelopmental delay, gestational hypertension, premature rupture of membranes, intrauterine growth restriction, and low birth weight. Additionally, women with SCH discovered in the second trimester had a higher incidence of stillbirth compared to those with normal thyroid function.",
    "is_verified": 1
  },
  {
    "question": "What did the large observational study find regarding elevated TSH levels during pregnancy?",
    "answer": "The large observational study found that elevated TSH levels above normal pregnancy values were associated with an increased risk of placental abruption (relative risk 3.0) and delivery before 34 weeks of gestation (relative risk 1.8).",
    "is_verified": 1
  },
  {
    "question": "What was the outcome of the intermediate-quality cohort study involving 1,017 women with singleton pregnancies regarding SCH?",
    "answer": "The intermediate-quality cohort study found that SCH was associated with increased risks of fetal distress, preterm delivery, poor vision in infants, fetal loss, and neurodevelopmental delay, although the absolute risk was relatively small. The study did not find differences in 35 other obstetrical outcomes related to SCH.",
    "is_verified": 1
  },
  {
    "question": "What are the limitations of the studies mentioned in the excerpt?",
    "answer": "The limitations include the small number of cases in the study of 1,017 women, which makes it difficult to draw strong conclusions, and the reliance on second-trimester values in the larger observational study, which may not align with the aims of the current research.",
    "is_verified": 1
  },
  {
    "question": "What is the association between first-trimester subclinical hypothyroidism (SCH) and adverse obstetric outcomes?",
    "answer": "The study's overall findings do not suggest an association of first-trimester SCH with adverse obstetric outcomes.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding TSH levels between 2.5 and 4.0 mIU/L in women undergoing ART treatment?",
    "answer": "In a cohort study of over 1,200 ART treatment cycles, 23% of women had TSH levels in the range of 2.5–4.0 mIU/L, and these patients did not demonstrate greater adverse pregnancy outcomes such as premature delivery or low birth weight.",
    "is_verified": 1
  },
  {
    "question": "What was the incidence of adverse pregnancy outcomes in women with varying TSH levels?",
    "answer": "In a study involving 184,611 women, the overall incidence of adverse pregnancy outcomes was 28.6%. Midrange TSH levels (2.50–4.29 mIU/L) were associated with preterm birth and operative vaginal delivery. True SCH (TSH level of 4.29–10 mIU/L) was correlated with stillbirth, preterm birth, cesarean section, and large for gestational age infants.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding TSH levels of 2.5–5.0 mIU/L in a cohort of pregnant women?",
    "answer": "In a retrospective cohort study of 1,981 pregnant women, TSH levels of 2.5–5.0 mIU/L showed no association with prematurity, preeclampsia, dystocia labor, or stillbirths; however, there was an increase in pregnancy loss. True SCH (TSH levels >5 mIU/L) was not associated with any adverse outcomes.",
    "is_verified": 1
  },
  {
    "question": "What association did Sitoris et al. find regarding SCH and preeclampsia?",
    "answer": "Sitoris et al. performed a retrospective cohort study that demonstrated SCH to be associated with preeclampsia but not with small or large for gestational age, neonatal intensive care unit admission, or preterm births.",
    "is_verified": 1
  },
  {
    "question": "What are some adverse obstetric outcomes associated with SCH?",
    "answer": "The adverse obstetric outcomes associated with SCH include preeclampsia, small for gestational age, and preterm delivery.",
    "is_verified": 1
  },
  {
    "question": "What is the association between subclinical hypothyroidism (SCH) during pregnancy and obstetric outcomes?",
    "answer": "Moderate-quality evidence suggests that SCH during pregnancy is not associated with adverse obstetric outcomes. While some studies indicate an increased risk, particularly with testing later in pregnancy, higher-quality studies predominantly show no increased risk when testing is done in the preconception and first trimester periods.",
    "is_verified": 1
  },
  {
    "question": "How does untreated hypothyroidism during pregnancy affect fetal development?",
    "answer": "Untreated hypothyroidism during pregnancy may delay fetal neurological maturation and development, impair school performance, and lower the intelligence quotient (IQ) of offspring. Overt maternal hypothyroidism has been associated with adverse effects on developmental outcomes, although recent randomized controlled trials (RCTs) have not demonstrated a consistent association between maternal subclinical hypothyroidism (SCH) and developmental outcomes in children.",
    "is_verified": 1
  },
  {
    "question": "What evidence exists regarding the impact of maternal SCH on children's intellectual development?",
    "answer": "Low- or intermediate-quality studies have suggested an association between maternal SCH and reduced intellectual development in children. A low-quality retrospective cohort study indicated that isolated levels of TSH may influence cognition, with children born to mothers with SCH in the second trimester showing an eight-point lower IQ compared to controls.",
    "is_verified": 1
  },
  {
    "question": "What is the association between maternal serum thyroid hormones and neurodevelopmental delay in children?",
    "answer": "A low-quality cohort study of 1,017 women found that subclinical hypothyroidism (SCH) was associated with increased neurodevelopmental delay, with an adjusted odds ratio (aOR) of 10.49. However, this finding was based on a single case of delay, leading to a wide confidence interval (CI) and was only significant in one statistical model.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding maternal TSH levels and neurodevelopment outcomes?",
    "answer": "Another study evaluated 39 women with SCH and found no differences in neurodevelopment of their offspring compared to 700 women without SCH, except for a statistically significant one-point difference in receptive communication scores in 1-year-old children. Additionally, a study of 143 maternal TSH levels at delivery found that higher TSH levels were associated with more neurocognitive issues in children at 5.5 years of age, with mild maternal hypothyroidism linked to a significant decline in verbal and perceptual performance.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between subclinical hypothyroidism (SCH) and neurodevelopmental outcomes in offspring?",
    "answer": "Three randomized controlled trials (RCTs) have provided evidence that subclinical hypothyroidism (SCH) is not associated with adverse neurodevelopmental outcomes in offspring. Prior observational studies were limited due to heterogeneous populations and confounding factors. In a high-quality RCT, cognitive function at 3 years of age was assessed in children of women who underwent thyroid screening and were treated with levothyroxine compared to controls. The results showed no significant difference in IQ testing between the two groups, indicating no benefit of routine screening for maternal hypothyroidism at early gestation in preventing impaired cognitive function in children.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding TSH levels and cognitive function in children?",
    "answer": "The study found no association between thyrotropin (TSH) levels and IQ in children. The median gestational age at screening was 12 weeks, and treatment began one week later. The results of IQ testing at age 3 did not differ significantly between the group treated for high TSH and the control group whose serum was tested after pregnancy. This suggests that routine screening for maternal hypothyroidism may not be necessary for preventing cognitive impairment in children.",
    "is_verified": 1
  },
  {
    "question": "What does the follow-up study indicate about cognitive function in children of mothers with SCH?",
    "answer": "A high-quality follow-up study assessed cognitive function at age 9 years in children of mothers with SCH who were randomly assigned to treatment and compared to a group of euthyroid women. The findings suggested that SCH was unrelated to neurodevelopmental outcomes, although the study lacked a euthyroid control group for comparison, which limits the conclusions that can be drawn.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of gestational thyroid levels in relation to children's IQ?",
    "answer": "The excerpt indicates that there was no difference in IQ (Intelligence Quotient) below 85 between children of mothers with normal gestational thyroid levels. This suggests that normal thyroid function during gestation may not significantly impact the cognitive development of the child as measured by IQ.",
    "is_verified": 1
  },
  {
    "question": "What is the effect of subclinical hypothyroidism (SCH) on offspring intelligence and cognition during pregnancy?",
    "answer": "There is no effect of low thyroid function on offspring intelligence or cognition, and no benefit to screening or treating SCH in pregnancy regarding neurological development.",
    "is_verified": 1
  },
  {
    "question": "What is the evidence regarding SCH in pregnancy and adverse neurodevelopmental outcomes in offspring?",
    "answer": "There is strong evidence that SCH in pregnancy is not associated with adverse neurodevelopmental outcomes in offspring.",
    "is_verified": 1
  },
  {
    "question": "What are the recommendations for counseling women regarding SCH in pregnancy?",
    "answer": "It is recommended that women be counseled that SCH in pregnancy is not associated with adverse neurodevelopmental outcomes in offspring, with a strong strength of evidence and recommendation.",
    "is_verified": 1
  },
  {
    "question": "Does levothyroxine treatment improve miscarriage rates, live-birth rates, or clinical pregnancy rates among women with SCH?",
    "answer": "Most studies demonstrated no improvement in miscarriage rates, live-birth rates, or clinical pregnancy rates with levothyroxine treatment among women with SCH, although one intermediate-quality randomized trial showed a significantly higher live-birth rate in the levothyroxine group compared to the control group.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding miscarriage rates in the study of infertile patients with SCH undergoing IVF treatment?",
    "answer": "In the study, the miscarriage rate was significantly higher in the control group compared to the treatment group, with 33% in the control group and 0% in the levothyroxine group among patients with a clinical pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of treating subclinical hypothyroidism (SCH) in infertile women according to the study?",
    "answer": "The study indicated that treating subclinical hypothyroidism (SCH) may show some benefit, as evidenced by a difference in pregnancy losses between treated and untreated groups. However, the data were insufficient to propose universal screening and treatment of SCH in infertile women due to the small study size and the risk of type I error.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding TPOAb positivity and miscarriage rates in the randomized trial?",
    "answer": "In the randomized trial, 15% of the 484 euthyroid women with infertility tested positive for TPO antibodies (TPOAbs). Among these women, treatment with levothyroxine did not significantly reduce the risk of miscarriage, with rates of 33% in the treatment group compared to 52% in the placebo group, and the difference was not statistically significant (P=0.24).",
    "is_verified": 1
  },
  {
    "question": "What were the outcomes of the randomized trial that involved thyroid screening for pregnant women?",
    "answer": "The randomized trial involving thyroid screening for pregnant women found no difference in the primary outcome of neurocognitive development between those screened and treated for SCH and those who were not screened. Although the study did not directly report on pregnancy loss or live birth rates, it provided data indicating no significant difference in the percentage of subjects who had a 3-year-old child from the delivery between the screening and control groups (78.1% vs. 73.3%, P=0.09).",
    "is_verified": 1
  },
  {
    "question": "What does the excerpt say about pregnancy loss rates in the control and treatment arms of the study?",
    "answer": "The excerpt mentions that the investigators reported pregnancy loss as 13% in the control arm and 9% in the treatment arm, with a reported P value of .03. However, this P value was later questioned and recalculated to P=.44, indicating no difference in pregnancy loss after addressing data integrity concerns.",
    "is_verified": 1
  },
  {
    "question": "What concerns were raised about the randomized trial by Abdel Rahman et al.?",
    "answer": "The trial was excluded due to unclear data reporting and major data integrity concerns. The reported outcomes were inconsistent, and the P values did not align with the data provided, leading to significant doubts about the validity of the trial's findings.",
    "is_verified": 1
  },
  {
    "question": "What was the outcome of the Cochrane review regarding the study by Abdel Rahman et al.?",
    "answer": "The Cochrane review decided to exclude the study by Abdel Rahman et al. from its analysis due to high risks of error in the data, which was a significant change from previous systematic reviews and meta-analyses that included it.",
    "is_verified": 1
  },
  {
    "question": "How did the ASRM Guideline change regarding the study by Abdel Rahman et al.?",
    "answer": "The ASRM Guideline decided to exclude the study from Abdel Rahman et al. due to concerns over the validity of the trial, marking a change from the prior version of the guidelines on treating subclinical hypothyroidism (SCH).",
    "is_verified": 1
  },
  {
    "question": "What was the effect size on clinical pregnancy outcomes reported by man et al.?",
    "answer": "The effect size on clinical pregnancy outcomes reported by man et al. was 100% with treatment and 28% without treatment, indicating a relative risk (RR) that is 4–8 times larger than the RRs in any other randomized trial.",
    "is_verified": 1
  },
  {
    "question": "What is the impact of levothyroxine treatment on clinical pregnancy rates in women with SCH undergoing IVF?",
    "answer": "Levothyroxine treatment was not associated with clinical pregnancy rate (RR 1.46; 95% CI 0.86–2.48).",
    "is_verified": 1
  },
  {
    "question": "How does levothyroxine treatment affect miscarriage rates in women with SCH undergoing IVF?",
    "answer": "Miscarriage was significantly lower in the levothyroxine group compared with the control group (RR 0.51; 95% CI 0.32–0.82).",
    "is_verified": 1
  },
  {
    "question": "What do international society guidelines say about the evidence for levothyroxine treatment in women desiring pregnancy or pregnant women with SCH?",
    "answer": "Many society guidelines discuss that the evidence is weak or lacking to demonstrate the benefit of levothyroxine treatment for SCH in women desiring pregnancy or pregnant, despite it being inexpensive and unlikely to cause harm.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of the systematic review and meta-analysis mentioned in the excerpt?",
    "answer": "A high-quality systematic review and meta-analysis of four RCTs included 787 women with SCH or TAI undergoing IVF treatment, highlighting the lack of association of levothyroxine treatment with clinical pregnancy rates and its significant impact on reducing miscarriage rates.",
    "is_verified": 1
  },
  {
    "question": "What was the outcome of the meta-analysis regarding pregnancy loss and levothyroxine treatment?",
    "answer": "The meta-analysis found no improvement in pregnancy loss with levothyroxine treatment when patients with TAI were excluded. Additionally, there was no difference in clinical pregnancy rates between groups.",
    "is_verified": 1
  },
  {
    "question": "What were the findings of the systematic review that included women with SCH treated with levothyroxine?",
    "answer": "The systematic review demonstrated a significantly higher live birth rate (LBR) and lower miscarriage rate among women treated with levothyroxine. However, these effects were largely driven by a retracted study, and excluding that study eliminated any significant associations between levothyroxine and the outcomes of interest.",
    "is_verified": 1
  },
  {
    "question": "What did the intermediate-quality retrospective cohort study find regarding levothyroxine treatment in pregnant women with SCH?",
    "answer": "The intermediate-quality retrospective cohort study of 5,405 pregnant women with SCH found that treatment with levothyroxine was associated with a significant reduction in the rate of pregnancy loss compared to no treatment.",
    "is_verified": 1
  },
  {
    "question": "What is the association between levothyroxine treatment and pregnancy outcomes in women with subclinical hypothyroidism (SCH)?",
    "answer": "Low- and intermediate-quality cohort studies and systematic reviews have not demonstrated significant associations between levothyroxine and pregnancy outcomes in women with SCH. There is moderate evidence that treatment of SCH with levothyroxine does not improve pregnancy loss, clinical pregnancy, or live birth outcomes. Therefore, it is not recommended to treat pregnant women or women desiring pregnancy who have a diagnosis of SCH with levothyroxine, as treatments have not been shown to reduce pregnancy loss or improve clinical pregnancy or live birth outcomes.",
    "is_verified": 1
  },
  {
    "question": "What should be tested in patients with signs or symptoms of hypothyroidism?",
    "answer": "Thyroid-stimulating hormone (TSH) and T4 levels should be tested in patients with signs or symptoms of hypothyroidism, such as irregular menstrual cycles, rather than in all patients with infertility.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation regarding the treatment of SCH in pregnant women?",
    "answer": "The recommendation is to not treat SCH in pregnant women or women desiring pregnancy, as there is a lack of quality clinical trials demonstrating the benefit of treating SCH for pregnancy outcomes.",
    "is_verified": 1
  },
  {
    "question": "What was reported about the association of SCH with neurodevelopmental outcomes?",
    "answer": "An association of SCH with decreased neurodevelopmental outcomes was reported in several observational studies of low- to intermediate-quality grading.",
    "is_verified": 1
  },
  {
    "question": "What is the association of early pregnancy serum TSH with infant developmental outcomes?",
    "answer": "Observational studies have found no association of early pregnancy serum TSH with infant developmental outcomes.",
    "is_verified": 1
  },
  {
    "question": "What was the purpose of the high-quality RCT regarding antenatal thyroid screening?",
    "answer": "The purpose of the high-quality RCT was to evaluate the effectiveness of antenatal thyroid screening on childhood cognitive function in pregnant women at a gestational age of 15 weeks and 6 days, specifically by analyzing TSH and free T4 levels to determine their impact on offspring neurocognitive development.",
    "is_verified": 1
  },
  {
    "question": "What were the criteria for diagnosing subclinical hypothyroidism (SCH) in pregnant women in the study?",
    "answer": "Subclinical hypothyroidism (SCH) in pregnant women was defined as a TSH level greater than 4 mIU/L with a normal free T4 level.",
    "is_verified": 1
  },
  {
    "question": "What treatment was given to women diagnosed with SCH in the study?",
    "answer": "Women diagnosed with subclinical hypothyroidism (SCH) were assigned to receive 150 mg of L-T4 (levothyroxine) per day as treatment.",
    "is_verified": 1
  },
  {
    "question": "What were the primary outcomes measured in the trials regarding the children of women with positive screening for SCH?",
    "answer": "The primary outcomes measured were the IQ scores of the children at 3 years and 5 years of age, as well as developmental and behavioral testing for 5 years.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding the IQ scores of children born to women treated for SCH compared to controls?",
    "answer": "The findings indicated that there were no significant differences in mean IQ scores between children of women with a positive screening and treatment for SCH compared to those in the control group, with specific IQ means reported for both groups and a P-value indicating no statistical significance.",
    "is_verified": 1
  },
  {
    "question": "What is the effect of levothyroxine treatment on pregnancy outcomes in women with subclinical hypothyroidism (SCH)?",
    "answer": "A systematic review and meta-analysis found no evidence of the benefit of levothyroxine therapy on obstetrical, neonatal, childhood IQ, or neurodevelopmental outcomes in women with SCH diagnosed in pregnancy. Therefore, levothyroxine therapy for SCH diagnosed in pregnancy is not recommended for improving developmental outcomes.",
    "is_verified": 1
  },
  {
    "question": "Are thyroid antibodies associated with infertility or adverse reproductive outcomes?",
    "answer": "A population study found that antithyroid antibodies were more prevalent in women than men and were significantly associated with hypo- or hyperthyroidism. A systematic review and meta-analysis indicated that the presence of thyroid antibodies was associated with an increased risk of unexplained subfertility (OR 1.5), miscarriage (OR 3.73), and recurrent miscarriage (OR 2.3).",
    "is_verified": 1
  },
  {
    "question": "What is the association between thyroid antibodies and miscarriage rates?",
    "answer": "Studies indicate that there is an increased miscarriage rate in patients with thyroid autoimmunity (TAI), even when thyroid-stimulating hormone (TSH) levels are normal. Specifically, a retrospective study found a higher miscarriage rate in untreated TPOAb+ patients compared to those who were treated. However, not all studies agree, as one prospective cohort study found no increased risk of pregnancy loss in women with TAI.",
    "is_verified": 1
  },
  {
    "question": "What are the implications of untreated subclinical hypothyroidism (SCH) in women with a history of pregnancy loss?",
    "answer": "Cost-effectiveness analyses suggest that women with a history of pregnancy loss and untreated subclinical hypothyroidism (SCH) or autoimmune thyroid disease (ATD) incur higher costs. Universal screening for ATD has been found to be cost-effective, highlighting the importance of treatment in these populations.",
    "is_verified": 1
  },
  {
    "question": "What were the findings regarding the impact of levothyroxine on pregnancy outcomes?",
    "answer": "A systematic review and meta-analyses focused on the treatment effect of levothyroxine on the pregnancy outcomes of women, indicating that treatment may have beneficial effects on pregnancy outcomes in women with thyroid issues, although specific results from this review are not detailed in the excerpt.",
    "is_verified": 1
  },
  {
    "question": "What was the finding of the study regarding miscarriage risk in patients undergoing IVF treatment?",
    "answer": "The study found a significantly decreased miscarriage risk in patients with SCH and/or TAI who underwent IVF treatment compared to those receiving a placebo or no treatment, with a relative risk (RR) of 0.51 and a 95% confidence interval (CI).",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between thyroid antibodies and miscarriage in women undergoing ART treatment?",
    "answer": "A prospective trial found a higher miscarriage rate in TPOAb-positive patients undergoing ART treatment. However, other studies did not find a significant effect of thyroid autoantibodies on ART treatment success. In a study of 487 patients who conceived successfully with ART, the rate of thyroid antibodies was 22%, but pregnancy rates were similar between those with and without antibodies. Additionally, a retrospective study of 416 euthyroid women showed no differences in pregnancy and delivery rates between women with and without antibodies. Women with TPOAb who miscarried had higher TSH values before ART treatment compared to those who delivered and those who were antibody-negative.",
    "is_verified": 1
  },
  {
    "question": "Is there evidence to support screening for thyroid autoantibodies in infertile or pregnant women?",
    "answer": "The evidence is insufficient to recommend screening for thyroid autoantibodies (TAI) in asymptomatic women with infertility or pregnancy. Targeted screening may be considered for women with a history of recurrent pregnancy loss (RPL), but the strength of evidence is weak.",
    "is_verified": 1
  },
  {
    "question": "How do thyroid hormone requirements change during pregnancy?",
    "answer": "Thyroid hormone requirements increase during gestation, and median TSH values are lower in the first trimester of pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of TSH reference ranges in pregnancy?",
    "answer": "The establishment and monitoring of TSH reference ranges by individual laboratories are crucial for the interpretation of measurements during pregnancy, particularly in assessing thyroid function and managing conditions like subclinical hypothyroidism (SCH).",
    "is_verified": 1
  },
  {
    "question": "What are the recommendations regarding screening for hypothyroidism in the first trimester of pregnancy?",
    "answer": "Most professional organizations recommend against universal routine screening for hypothyroidism in the first trimester and suggest a risk-based approach instead. The American College of Obstetrics and Gynecology specifically recommends testing thyroid function in women with a personal or family history of thyroid disease, type 1 diabetes mellitus, or clinical suspicion of thyroid disease.",
    "is_verified": 1
  },
  {
    "question": "What did the retrospective study on women with identified SCH reveal about spontaneous abortion rates?",
    "answer": "The retrospective study demonstrated that participants with identified subclinical hypothyroidism (SCH) had a significantly higher rate of spontaneous abortion (15.48% vs. 8.86%, P=0.03) compared to those without SCH, although there were no increased rates of obstetric or neonatal outcomes.",
    "is_verified": 1
  },
  {
    "question": "What was found regarding the treatment of SCH with levothyroxine in relation to spontaneous abortion?",
    "answer": "In the study, no statistically significant decrease in the incidence of spontaneous abortion was demonstrated in women with a diagnosis of SCH who were treated with levothyroxine compared to those who remained untreated.",
    "is_verified": 1
  },
  {
    "question": "What correlation was found between TSH levels and fetal deaths?",
    "answer": "One retrospective cohort study found a significantly higher rate of fetal deaths in the 2.2% of 9,403 women who had TSH levels greater than or equal to 6 mIU/L compared to women whose TSH levels were less than 6 mIU/L (0.9%: OR 4.4; 95% CI, 1.9–9.5), although this did not represent true subclinical hypothyroidism (SCH).",
    "is_verified": 1
  },
  {
    "question": "What did the decision-analytic models analyze regarding SCH screening during pregnancy?",
    "answer": "Two studies based on decision-analytic models sought to analyze the cost-effectiveness of routine screening for subclinical hypothyroidism (SCH) during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of routine screening of TSH levels?",
    "answer": "Routine screening of TSH levels has been shown to result in cost savings and gained quality-adjusted life years compared to no routine screening. This suggests that regular monitoring of thyroid-stimulating hormone (TSH) can improve health outcomes and be economically beneficial.",
    "is_verified": 1
  },
  {
    "question": "What treatment was given to women with elevated TSH levels in the study?",
    "answer": "In the study, women with TSH levels exceeding 1 mIU/L who were positive for antithyroid peroxidase antibodies (TPOAb+) were treated with 50mg of levothyroxine.",
    "is_verified": 1
  },
  {
    "question": "What was the outcome of treating women with levothyroxine compared to no treatment?",
    "answer": "The treatment with levothyroxine was associated with a significantly lower spontaneous abortion rate (0% in treated women vs. 16% in untreated women, P=0.02).",
    "is_verified": 1
  },
  {
    "question": "What did the high-quality RCT report regarding antenatal thyroid screening?",
    "answer": "The high-quality randomized controlled trial (RCT) reported no benefit of antenatal thyroid screening concerning childhood cognitive function, indicating that screening may not improve cognitive outcomes in children.",
    "is_verified": 1
  },
  {
    "question": "What were the two strategies compared in the high-quality RCT regarding thyroid disease screening?",
    "answer": "The RCT compared a universal screening strategy with a case-finding strategy, where women were either tested for FT4, TSH, and TPOAbs levels immediately or only when risk factors for thyroid disease were identified.",
    "is_verified": 1
  },
  {
    "question": "What is the percentage of low-risk women with thyroid abnormalities who experienced at least one adverse outcome in the universal screening arm?",
    "answer": "37.3% (19/51) of low-risk women with thyroid abnormalities experienced at least one adverse outcome in the universal screening arm.",
    "is_verified": 1
  },
  {
    "question": "What percentage of low-risk women identified as hypo- or hyper-thyroid in the case-finding arm had at least one adverse outcome?",
    "answer": "92.3% (36 of 39) of low-risk women identified as hypo- or hyper-thyroid in the case-finding arm had at least one adverse outcome.",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation for women with known hypothyroidism treated with levothyroxine before conception regarding their dosage in the first trimester?",
    "answer": "Women with known hypothyroidism treated with levothyroxine before conception should plan to increase their dosage by 30%–60% in the first trimester.",
    "is_verified": 1
  },
  {
    "question": "What monitoring is recommended for women with preconceptional autoimmune thyroid disease (ATD) during pregnancy?",
    "answer": "Women with preconceptional autoimmune thyroid disease (ATD) should undergo regular TSH level monitoring during pregnancy, as they are at increased risk for gestational thyroid insufficiency and postpartum thyroiditis.",
    "is_verified": 1
  },
  {
    "question": "What does the current evidence suggest about universal screening of thyroid function during pregnancy?",
    "answer": "The current evidence suggests that universal screening of thyroid function during pregnancy does not result in a decrease in adverse outcomes and is not recommended.",
    "is_verified": 1
  },
  {
    "question": "What is the strength of evidence and recommendation for screening thyroid function during pregnancy in patients at increased risk of overt hypothyroidism?",
    "answer": "The strength of evidence is B and the strength of recommendation is moderate for screening thyroid function during pregnancy with a serum thyrotropin level in patients at increased risk of overt hypothyroidism.",
    "is_verified": 1
  },
  {
    "question": "What are the associated risks of levothyroxine therapy?",
    "answer": "The associated risks of levothyroxine therapy include heat intolerance, sweats, chills, heart palpitations, arrhythmia, diarrhea, weight change, hair thinning, tremors, mood changes, sleep disturbances, fatigue, anxiety, and bone loss.",
    "is_verified": 1
  },
  {
    "question": "What is the goal TSH level mentioned in the excerpt, and what issue does it cause for women?",
    "answer": "The goal TSH level mentioned is <2.5 mIU/L, and achieving this level has resulted in significant delays in women receiving appropriate infertility treatment or initiating an IVF treatment cycle.",
    "is_verified": 1
  },
  {
    "question": "What does the excerpt say about the evidence for screening and treatment of SCH in women with infertility or pregnancy?",
    "answer": "The excerpt states that most evidence advocating for screening and treatment of SCH in women with infertility or pregnancy is based on low-quality observational data and one clinical trial, which should be withdrawn due to significant concerns over data integrity. It is not recommended to screen or treat for asymptomatic SCH in these women based on current evidence.",
    "is_verified": 1
  },
  {
    "question": "What recommendations are made regarding the treatment of SCH and routine screening?",
    "answer": "Practitioners are encouraged to use caution and not recommend routine screening and treatment for SCH in women with infertility or pregnancy, especially in the absence of demonstrable benefit.",
    "is_verified": 1
  },
  {
    "question": "What additional clinical trials are mentioned as necessary in the excerpt?",
    "answer": "The excerpt mentions that additional clinical trials evaluating the treatment of SCH to improve offspring neurocognitive development, the screening and treatment of antithyroid antibodies and pregnancy outcomes, and the screening and treatment of SCH in infertile patients and those receiving IVF therapies are needed.",
    "is_verified": 1
  },
  {
    "question": "What are the recommended TSH levels for nonpregnant and pregnant patients with SCH?",
    "answer": "TSH levels between 2.5 and 4 mIU/L are recommended for both nonpregnant and pregnant patients with SCH, as they are not associated with an increased risk of miscarriage.",
    "is_verified": 1
  },
  {
    "question": "Is SCH associated with an increased risk of miscarriage?",
    "answer": "No, SCH is not associated with an increased risk of miscarriage according to the recommendations.",
    "is_verified": 1
  },
  {
    "question": "What is the evidence regarding SCH and infertility?",
    "answer": "There is insufficient evidence to counsel women that SCH is associated with infertility, with a strength of evidence rated as C (weak).",
    "is_verified": 1
  },
  {
    "question": "What are the recommendations regarding the treatment of women with SCH who desire pregnancy?",
    "answer": "It is not recommended to treat women desiring pregnancy or already pregnant who have a diagnosis of SCH with levothyroxine, as treatment has not been proven to reduce pregnancy loss or improve clinical pregnancy or live birth outcomes.",
    "is_verified": 1
  },
  {
    "question": "Is SCH associated with increased obstetric risk?",
    "answer": "No, SCH is not associated with increased obstetric risk according to the recommendations.",
    "is_verified": 1
  },
  {
    "question": "What are the recommendations regarding neurodevelopmental outcomes in offspring of women with SCH?",
    "answer": "It is recommended that women be counseled that SCH is not associated with adverse neurodevelopmental outcomes in offspring, with a strength of evidence rated as A (strong).",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation regarding Levothyroxine therapy for SCH diagnosed in pregnancy?",
    "answer": "Levothyroxine therapy of subclinical hypothyroidism (SCH) diagnosed in pregnancy is not recommended for the indication of improving developmental outcomes, with a strong recommendation against it (strength of evidence: A; strength of recommendation: strong).",
    "is_verified": 1
  },
  {
    "question": "Is screening for TAI recommended in asymptomatic women with infertility or pregnancy?",
    "answer": "It is not recommended to screen for thyroid autoimmunity (TAI) in asymptomatic women with infertility or pregnancy. However, targeted screening may be considered in women with a history of recurrent pregnancy loss (RPL), but this has a weak recommendation (strength of evidence C; strength of recommendation weak).",
    "is_verified": 1
  },
  {
    "question": "What is the recommendation for universal screening of thyroid function during pregnancy?",
    "answer": "Universal screening of thyroid function during pregnancy is not recommended (strength of evidence: B; strength of recommendation: moderate).",
    "is_verified": 1
  },
  {
    "question": "When should thyroid function screening be conducted during pregnancy?",
    "answer": "Screening of thyroid function during pregnancy with a serum thyrotropin level is recommended for patients at increased risk (strength of evidence: B; strength of recommendation: moderate).",
    "is_verified": 1
  },
  {
    "question": "What should be tested in patients with signs or symptoms of hypothyroidism?",
    "answer": "Thyroid-stimulating hormone (TSH) and T4 levels should be tested in patients with signs or symptoms of hypothyroidism (including irregular menstrual cycles) rather than in all patients with infertility (strength of evidence: B; strength of recommendation: moderate).",
    "is_verified": 1
  },
  {
    "question": "What is the role of the American Society for Reproductive Medicine (ASRM) Practice Committee?",
    "answer": "The ASRM Practice Committee is responsible for developing and reviewing guidelines and recommendations for clinicians in the field of reproductive medicine. They acknowledge contributions from various medical professionals and ensure that the guidelines reflect appropriate management of problems encountered in reproductive medicine.",
    "is_verified": 1
  },
  {
    "question": "What does the disclaimer in the document indicate about the guidelines?",
    "answer": "The disclaimer indicates that while the guidelines reflect appropriate management practices in reproductive medicine, they are not intended to be the only approved standard of practice. It emphasizes that other management plans may be appropriate based on individual patient needs and clinical circumstances.",
    "is_verified": 1
  },
  {
    "question": "What is the role of the American Society for Reproductive Medicine (ASRM) in the development of clinical practice guidelines?",
    "answer": "The ASRM, through its Practice Committee and a task force of medical experts, is involved in the development of clinical practice guidelines related to reproductive medicine. This includes specialists in various fields such as obstetrics, gynecology, reproductive endocrinology, infertility, and assisted reproductive technology. The committee reviews documents at various stages and incorporates feedback from a diverse group of stakeholders, including patients and professionals from multiple disciplines.",
    "is_verified": 1
  },
  {
    "question": "Who are the members of the task force for the clinical practice guideline mentioned in the excerpt?",
    "answer": "The task force for the clinical practice guideline consists of medical professionals at various levels of training, including fellows, senior experts, and those with less than 10 years of post-training experience. It also includes Clinical Reproductive Scientist Training (CREST) Program scholars, a clinical epidemiologist who specializes in reproductive medicine, and a methodologic specialist.",
    "is_verified": 1
  },
  {
    "question": "What types of professionals were involved in the review process of the clinical practice guideline?",
    "answer": "The review process involved a multidisciplinary body that included patient advocates, genetic counselors, mental health professionals, nursing professionals, legal professionals, laboratory personnel, research scientists, and physicians boarded in one or more specialties. This diverse group provided input during the 15-day open review period.",
    "is_verified": 1
  },
  {
    "question": "How did the perspectives of patients influence the clinical practice guideline?",
    "answer": "A group of patient volunteers and lay stakeholders in reproductive medicine, who were not involved in the scoping or development of the guideline, reviewed the document. Their feedback was considered in the preparation of the final document to ensure that the perspectives of those affected by the recommendations were incorporated.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of thyroid health during pregnancy according to the references?",
    "answer": "The references highlight several important aspects of thyroid health during pregnancy. They indicate that maternal thyroid deficiency can lead to neuropsychological developmental issues in children (Haddow et al., 1999). Additionally, autoimmune thyroid disease in pregnant women can lead to obstetrical complications, which can be mitigated by levothyroxine treatment (Negro et al., 2006). The presence of overt and subclinical hypothyroidism complicating pregnancy is also noted (Abalovich et al., 2002), and thyroid autoimmunity is discussed in relation to hypothyroidism before and during pregnancy (Poppe & Glinoer, 2003). Overall, these studies suggest that proper management of thyroid function is crucial for both maternal and fetal health.",
    "is_verified": 1
  },
  {
    "question": "What are the clinical practice guidelines for hypothyroidism in adults?",
    "answer": "The clinical practice guidelines for hypothyroidism in adults are cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association, as detailed in the publication \"Endocr Pract 2012;18:988–1028.\"",
    "is_verified": 1
  },
  {
    "question": "What is the focus of the ACOG Practice Bulletin Number 223?",
    "answer": "The ACOG Practice Bulletin Number 223 focuses on Thyroid Disease in Pregnancy, as published in \"Obstet Gynecol 2020;135:e261–74.\"",
    "is_verified": 1
  },
  {
    "question": "What is the significance of the publication by Fatourechi V regarding subclinical hypothyroidism?",
    "answer": "Fatourechi V's publication titled \"Subclinical hypothyroidism: an update for primary care physicians\" provides an update on the condition and its management, as seen in \"Mayo Clin Proc 2009;84:65–71.\"",
    "is_verified": 1
  },
  {
    "question": "What does the laboratory medicine practice guidelines document address?",
    "answer": "The laboratory medicine practice guidelines document addresses laboratory support for the diagnosis and monitoring of thyroid disease, as detailed in \"Thyroid 2003;13:3–126.\"",
    "is_verified": 1
  },
  {
    "question": "What did the study by Haddow JE et al. investigate regarding thyroid stimulating hormone?",
    "answer": "The study by Haddow JE et al. investigated the reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy, published in \"J Med Screen 2004;11:170–4.\"",
    "is_verified": 1
  },
  {
    "question": "What issue is highlighted by Dong AC and Stagnaro-Green A regarding thyroid disease in pregnancy?",
    "answer": "Dong AC and Stagnaro-Green A highlighted that differences in diagnostic criteria mask the true prevalence of thyroid disease in pregnancy, as discussed in their systematic review and meta-analysis published in \"Thyroid 2019;29:278–89.\"",
    "is_verified": 1
  },
  {
    "question": "What are the effects of levothyroxine therapy on pregnancy outcomes in women with subclinical hypothyroidism?",
    "answer": "Levothyroxine therapy has been studied for its effects on pregnancy outcomes in women with subclinical hypothyroidism, indicating potential benefits in managing thyroid hormone levels during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the risk of miscarriage in patients with subclinical hypothyroidism before 20 weeks of pregnancy?",
    "answer": "Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage, as shown in a systematic review and meta-analysis.",
    "is_verified": 1
  },
  {
    "question": "How does borderline-subclinical hypothyroidism impact pregnancy outcomes in women with recurrent pregnancy loss?",
    "answer": "Borderline-subclinical hypothyroidism has been shown to impact subsequent pregnancy outcomes in women who have experienced unexplained recurrent pregnancy loss.",
    "is_verified": 1
  },
  {
    "question": "Is subclinical hypothyroidism associated with lower live birth rates in women with unexplained recurrent miscarriage?",
    "answer": "Research has investigated whether subclinical hypothyroidism is associated with lower live birth rates in women who have experienced unexplained recurrent miscarriage, with varying conclusions.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage?",
    "answer": "A prospective cohort study has examined the relationship between maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage, indicating potential risks associated with these conditions.",
    "is_verified": 1
  },
  {
    "question": "How do preconceptional serum TSH values affect live birth rates following ovulation induction and intrauterine insemination?",
    "answer": "Preconceptional serum thyroid stimulating hormone (TSH) values ranging between 2.5 and 4.5 mIU/L have been studied for their impact on live birth rates following ovulation induction and intrauterine insemination treatment for unexplained infertility.",
    "is_verified": 1
  },
  {
    "question": "What is the impact of TSH during the first trimester of pregnancy on obstetric and fetal complications?",
    "answer": "The study discusses the usefulness of a TSH cut-off value of 2.5 mIU/L during the first trimester of pregnancy in relation to obstetric and fetal complications.",
    "is_verified": 1
  },
  {
    "question": "How does thyroid function relate to early pregnancy loss in women?",
    "answer": "The research indicates that thyroid function in women who experience early pregnancy loss is significant, with specific findings reported in the study.",
    "is_verified": 1
  },
  {
    "question": "What are the pregnancy outcomes of antibody negative and untreated subclinical hypothyroidism?",
    "answer": "The study examines the pregnancy outcomes associated with antibody negative and untreated subclinical hypothyroidism, providing insights into maternal health during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What are the effects of maternal subclinical hypothyroidism diagnosed by different criteria on perinatal outcomes?",
    "answer": "The research highlights the adverse perinatal outcomes linked to maternal subclinical hypothyroidism diagnosed by varying criteria in Chinese women with negative TPOAb.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between preconception TSH levels and pregnancy outcomes?",
    "answer": "A population-based cohort study investigates the relationship between preconception TSH levels and pregnancy outcomes in a large sample of women.",
    "is_verified": 1
  },
  {
    "question": "How does thyroxine treatment affect pregnancy outcomes in infertile women with specific TSH levels?",
    "answer": "The retrospective study evaluates the effect of thyroxine treatment on pregnancy outcomes in infertile Japanese women with TSH levels between 2.5 mIU/mL and the upper reference limit.",
    "is_verified": 1
  },
  {
    "question": "What is the effect of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization?",
    "answer": "The study assesses how stricter TSH thresholds impact pregnancy outcomes for patients undergoing in vitro fertilization.",
    "is_verified": 1
  },
  {
    "question": "Do elevated TSH levels predict early pregnancy loss in ART patients?",
    "answer": "The research investigates whether elevated TSH levels can predict early pregnancy loss in patients undergoing assisted reproductive technology (ART).",
    "is_verified": 1
  },
  {
    "question": "What is the focus of the study by Chai et al. regarding in vitro fertilization?",
    "answer": "The study by Chai et al. focuses on live birth rates following in vitro fertilization in women who have thyroid autoimmunity and/or subclinical hypothyroidism.",
    "is_verified": 1
  },
  {
    "question": "What type of publication is 'Clin Endocrinol (Oxf)'?",
    "answer": "'Clin Endocrinol (Oxf)' is a clinical journal that publishes research related to endocrinology, including studies on thyroid conditions and their impact on reproductive health.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between maternal thyroid function and fetal death?",
    "answer": "The study by Ashoor et al. (2010) indicates that maternal thyroid function at 11 to 13 weeks of gestation is associated with subsequent fetal death, suggesting that thyroid health during early pregnancy is crucial for fetal survival.",
    "is_verified": 1
  },
  {
    "question": "How does subclinical hypothyroidism affect women with infertility?",
    "answer": "Abalovich et al. (2007) found that subclinical hypothyroidism and thyroid autoimmunity are prevalent in women with infertility, indicating a potential link between thyroid dysfunction and reproductive challenges.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of screening for hypothyroidism in infertile women?",
    "answer": "Lincoln et al. (1999) emphasize the importance of screening for hypothyroidism in infertile women, as it may help identify underlying issues that could be affecting fertility.",
    "is_verified": 1
  },
  {
    "question": "What are the implications of impaired fertility associated with subclinical hypothyroidism?",
    "answer": "Feldthusen et al. (2017) discuss the implications of impaired fertility linked to subclinical hypothyroidism and thyroid autoimmunity, highlighting the need for awareness and potential treatment options for affected women.",
    "is_verified": 1
  },
  {
    "question": "Should universal screening for thyroid disease during pregnancy be performed?",
    "answer": "Stagnaro-Green et al. (2020) advocate for universal screening for thyroid disease during pregnancy, suggesting that it is essential for maternal and fetal health outcomes.",
    "is_verified": 1
  },
  {
    "question": "What are the perinatal outcomes in hypothyroid pregnancies?",
    "answer": "Leung et al. (1993) studied perinatal outcomes in hypothyroid pregnancies and found that maternal hypothyroidism can negatively impact pregnancy outcomes, emphasizing the need for careful management.",
    "is_verified": 1
  },
  {
    "question": "How does subclinical hypothyroidism affect pregnancy outcomes?",
    "answer": "Casey et al. (2005) found that subclinical hypothyroidism can adversely affect pregnancy outcomes, indicating that monitoring thyroid function during pregnancy is important.",
    "is_verified": 1
  },
  {
    "question": "What effects does levothyroxine have on pregnant women with subclinical hypothyroidism?",
    "answer": "Nazarpour et al. (2018) investigated the effects of levothyroxine on pregnant women with subclinical hypothyroidism who were negative for thyroid peroxidase antibodies, suggesting that treatment may improve outcomes in this population.",
    "is_verified": 1
  },
  {
    "question": "How does maternal thyroid hypofunction impact pregnancy outcomes?",
    "answer": "Cleary-Goldman et al. (2008) examined the relationship between maternal thyroid hypofunction and pregnancy outcomes, finding that it can lead to adverse effects, reinforcing the importance of thyroid health during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the impact of maternal thyroid function in the first twenty weeks of pregnancy on fetal and infant development?",
    "answer": "Su et al. (2011) conducted a prospective population-based cohort study that showed maternal thyroid function in the first twenty weeks of pregnancy is crucial for subsequent fetal and infant development, highlighting the importance of monitoring thyroid levels during early pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What are the effects of maternal subclinical hypothyroidism on obstetrical outcomes during early pregnancy?",
    "answer": "Maternal subclinical hypothyroidism has been shown to affect obstetrical outcomes negatively during early pregnancy, as indicated by studies that highlight its association with complications and adverse outcomes for both the mother and the fetus.",
    "is_verified": 1
  },
  {
    "question": "What is the prevalence and impact of hypothyroidism in pregnancy according to studies from north India?",
    "answer": "Studies from north India have reported on the prevalence of hypothyroidism in pregnancy, identifying associated risk factors and its effects on pregnancy outcomes, including potential complications for both the mother and the child.",
    "is_verified": 1
  },
  {
    "question": "How does subclinical hypothyroidism affect maternal and perinatal outcomes during pregnancy?",
    "answer": "Research indicates that subclinical hypothyroidism can have significant effects on maternal and perinatal outcomes, potentially leading to complications such as preterm birth, low birth weight, and other adverse effects on fetal development.",
    "is_verified": 1
  },
  {
    "question": "What are the effects of screening and intervention for subclinical hypothyroidism on pregnancy outcomes?",
    "answer": "Screening and intervention for subclinical hypothyroidism during pregnancy have been shown to improve pregnancy outcomes, as evidenced by studies that demonstrate the benefits of thyroid function screening and subsequent treatment.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between preconception thyroid-stimulating hormone levels and adverse pregnancy outcomes?",
    "answer": "Higher preconception thyroid-stimulating hormone levels have been associated with an increased risk of adverse pregnancy outcomes, suggesting the importance of monitoring thyroid function prior to conception.",
    "is_verified": 1
  },
  {
    "question": "What are the effects of levothyroxine sodium tablets on pregnancy outcomes for women with subclinical hypothyroidism?",
    "answer": "Levothyroxine sodium tablets have been found to positively influence pregnancy outcomes and offspring development in women diagnosed with subclinical hypothyroidism, highlighting the importance of treatment during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the impact of thyroid disorders on clinical pregnancy outcomes?",
    "answer": "Thyroid disorders can significantly affect clinical pregnancy outcomes, as indicated by a study that assessed their impact in a real-world setting. The study highlights the importance of monitoring thyroid function in pregnant women to ensure better health outcomes for both the mother and the child.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between anti-thyroid peroxidase antibody positivity and pregnancy-related outcomes?",
    "answer": "A study found that there is a relationship between anti-thyroid peroxidase antibody positivity and pregnancy-related and fetal outcomes in euthyroid women, suggesting that even in women with normal thyroid function, the presence of these antibodies can influence pregnancy outcomes.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy?",
    "answer": "A systematic review indicated that (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and during early pregnancy are significant factors that can affect pregnancy outcomes, emphasizing the need for thyroid function assessment in women planning to conceive.",
    "is_verified": 1
  },
  {
    "question": "How do low maternal free thyroxine concentrations during early pregnancy affect child development?",
    "answer": "Low maternal free thyroxine concentrations during early pregnancy have been associated with impaired psychomotor development in infancy, indicating the critical role of thyroid hormones in fetal development.",
    "is_verified": 1
  },
  {
    "question": "What is the effect of antenatal thyroid screening on childhood cognitive function?",
    "answer": "Antenatal thyroid screening has been shown to have an effect on childhood cognitive function, with studies suggesting that identifying and treating thyroid dysfunction during pregnancy can lead to improved cognitive outcomes in children.",
    "is_verified": 1
  },
  {
    "question": "What are the effects of treating maternal sub-optimal thyroid function on child cognition?",
    "answer": "Treating maternal sub-optimal thyroid function during pregnancy has been shown to positively affect child cognition, highlighting the importance of managing thyroid health in expectant mothers.",
    "is_verified": 1
  },
  {
    "question": "What are the consequences of abnormalities in maternal thyroid function during pregnancy on neuropsychological development?",
    "answer": "Abnormalities in maternal thyroid function during pregnancy can adversely affect the neuropsychological development of children, as evidenced by studies tracking development at 25-30 months of age.",
    "is_verified": 1
  },
  {
    "question": "What is the treatment approach for subclinical hypothyroidism or hypothyroxinemia in pregnancy?",
    "answer": "The treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy has been explored in clinical studies, indicating that appropriate management can lead to better health outcomes for both the mother and the child.",
    "is_verified": 1
  },
  {
    "question": "What is the association between maternal thyroid dysfunction and neurodevelopmental outcomes in infants?",
    "answer": "Mild maternal thyroid dysfunction at delivery has been linked to neurodevelopmental outcomes in infants born preterm (34 weeks). Studies indicate that maternal mild hypothyroidism can affect the neurodevelopment of offspring, particularly in TPOAb-negative women, suggesting that thyroid function during pregnancy is crucial for the child's development.",
    "is_verified": 1
  },
  {
    "question": "How does levothyroxine treatment affect fertility in women with hypothyroidism?",
    "answer": "Levothyroxine treatment has been shown to improve in vitro fertilization (IVF) and pregnancy outcomes in infertile women with subclinical hypothyroidism. Studies indicate that treating subclinical hypothyroidism can lead to better IVF outcomes and overall fertility success rates.",
    "is_verified": 1
  },
  {
    "question": "What is the role of levothyroxine in assisted reproduction technologies?",
    "answer": "Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies has been studied, showing potential benefits in improving reproductive outcomes. This treatment is particularly relevant for women with autoimmune thyroid disease or subclinical hypothyroidism, as it may enhance the chances of successful conception and pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What evidence supports the use of thyroxine replacement in subfertile women with thyroid issues?",
    "answer": "Evidence from systematic reviews supports the use of thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism, indicating that such treatment may improve fertility outcomes and increase the likelihood of successful pregnancies.",
    "is_verified": 1
  },
  {
    "question": "What is subclinical hypothyroidism and how does it relate to pregnancy?",
    "answer": "Subclinical hypothyroidism is a condition where the thyroid gland does not produce enough hormones, but the deficiency is not severe enough to cause noticeable symptoms. In pregnancy, it can affect both maternal and fetal health, and studies suggest that it may be linked to adverse pregnancy outcomes. Systematic reviews and meta-analyses have been conducted to evaluate the impact of subclinical hypothyroidism on pregnancy and the effectiveness of treatments such as levothyroxine.",
    "is_verified": 1
  },
  {
    "question": "What are the implications of treating thyroid disorders before conception and in early pregnancy?",
    "answer": "Treating thyroid disorders before conception and in early pregnancy is crucial as it can help mitigate risks associated with thyroid dysfunction, such as complications during pregnancy and adverse outcomes for the baby. Systematic reviews indicate that proper management of thyroid levels can lead to better pregnancy outcomes and should be considered in women planning to conceive or who are in early pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the role of levothyroxine in managing subclinical hypothyroidism during pregnancy?",
    "answer": "Levothyroxine is a synthetic form of the thyroid hormone thyroxine (T4) and is used to treat hypothyroidism. In pregnant women with subclinical hypothyroidism, levothyroxine may reduce the risk of adverse pregnancy outcomes. Studies have shown that appropriate treatment with levothyroxine can help maintain normal thyroid hormone levels, which is essential for both maternal health and fetal development.",
    "is_verified": 1
  },
  {
    "question": "What is hypothyroidism?",
    "answer": "Hypothyroidism is a condition where the thyroid gland does not produce enough thyroid hormones, which can lead to various health issues, including complications during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the significance of levothyroxine sodium tablet administration in pregnant women with hypothyroidism?",
    "answer": "Levothyroxine sodium is a medication used to treat hypothyroidism. A systematic review and meta-analysis indicated its efficacy and positive pregnancy outcomes in pregnant women complicated with hypothyroidism.",
    "is_verified": 1
  },
  {
    "question": "What are the effects of subclinical hypothyroidism on pregnancy?",
    "answer": "Subclinical hypothyroidism can impact pregnancy outcomes, including recurrent early pregnancy loss and cognitive development of offspring, as indicated by various studies.",
    "is_verified": 1
  },
  {
    "question": "How does maternal hypothyroidism affect cognitive development in children?",
    "answer": "The severity of maternal hypothyroidism has been related to cognitive development issues in offspring, highlighting the importance of thyroid function during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between thyroid function and child neurodevelopment?",
    "answer": "Thyroxine levels during pregnancy in healthy women have been associated with early child neurodevelopment, indicating the critical role of thyroid hormones in fetal development.",
    "is_verified": 1
  },
  {
    "question": "What is the impact of screening for autoimmune thyroid disorders after spontaneous abortion?",
    "answer": "Screening for autoimmune thyroid disorders after spontaneous abortion is considered cost-saving and can improve subsequent pregnancy rates, emphasizing the importance of thyroid health in reproductive outcomes.",
    "is_verified": 1
  },
  {
    "question": "What is subclinical hypothyroidism and how is it diagnosed in pregnancy?",
    "answer": "Subclinical hypothyroidism is a condition characterized by elevated thyroid-stimulating hormone (TSH) levels with normal free thyroxine (T4) levels. It is diagnosed in pregnancy through systematic reviews and meta-analyses of randomized controlled trials, which assess the prevalence and implications of this condition in pregnant women.",
    "is_verified": 1
  },
  {
    "question": "What is the influence of thyroid autoimmunity and maternal age on the risk of miscarriage?",
    "answer": "Thyroid autoimmunity and maternal age have been shown to influence the risk of miscarriage, with studies indicating that women with positive thyroid autoimmunity may have a higher risk of miscarriage, particularly as maternal age increases.",
    "is_verified": 1
  },
  {
    "question": "How does positive thyroid autoimmunity affect pregnant women with subclinical hypothyroidism?",
    "answer": "Positive thyroid autoimmunity can exacerbate the risks associated with subclinical hypothyroidism in pregnant women, potentially leading to adverse pregnancy outcomes such as miscarriage and complications during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What is the risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders?",
    "answer": "Pregnant women with asymptomatic autoimmune thyroid disorders are at an increased risk of developing subclinical hypothyroidism, which can have implications for both maternal and fetal health.",
    "is_verified": 1
  },
  {
    "question": "What is the relationship between thyroid autoimmunity and recurrent spontaneous abortion?",
    "answer": "There is a significant relationship between thyroid autoimmunity and recurrent spontaneous abortion, as evidenced by case-control studies that show women with thyroid autoimmunity may experience higher rates of miscarriage.",
    "is_verified": 1
  },
  {
    "question": "What impact does universal screening and treatment of thyroid autoimmune diseases have on miscarriage rates?",
    "answer": "Universal screening and treatment of thyroid autoimmune diseases have been shown to reduce miscarriage rates, highlighting the importance of early detection and management in pregnant women.",
    "is_verified": 1
  },
  {
    "question": "What is the cost-effectiveness of screening for autoimmune thyroid disease in pregnant women?",
    "answer": "Studies have evaluated the cost-effectiveness of both universal and risk-based screening for autoimmune thyroid disease in pregnant women, indicating that proactive screening can lead to better health outcomes and potentially lower healthcare costs associated with untreated thyroid conditions during pregnancy.",
    "is_verified": 1
  },
  {
    "question": "What role does autoimmunity and thyroid function play in euthyroid women undergoing assisted reproduction technologies?",
    "answer": "In euthyroid women with autoimmune disease undergoing assisted reproduction technologies, the role of autoimmunity and thyroid function is critical, as these factors can influence the success rates of assisted reproductive procedures.",
    "is_verified": 1
  },
  {
    "question": "What are the clinical practice guidelines for hypothyroidism in adults?",
    "answer": "Clinical practice guidelines for hypothyroidism in adults provide recommendations for diagnosis, management, and treatment of hypothyroidism, ensuring that patients receive appropriate care based on current evidence and best practices.",
    "is_verified": 1
  },
  {
    "question": "What is the management guideline for thyroid dysfunction during pregnancy and postpartum?",
    "answer": "The management of thyroid dysfunction during pregnancy and postpartum is outlined in the Endocrine Society clinical practice guideline, which emphasizes the importance of monitoring and treating thyroid hormone levels to ensure maternal and fetal health.",
    "is_verified": 1
  },
  {
    "question": "What are the implications of maternal thyroid deficiency on pregnancy complications?",
    "answer": "Maternal thyroid deficiency can lead to various pregnancy complications, and this has implications for population screening to identify and treat thyroid dysfunction in pregnant women.",
    "is_verified": 1
  },
  {
    "question": "What is the cost-effectiveness of universal screening for subclinical hypothyroidism in pregnancy?",
    "answer": "The cost-effectiveness of universal screening for subclinical hypothyroidism during pregnancy has been studied, indicating that such screening may be beneficial in preventing complications associated with untreated thyroid dysfunction.",
    "is_verified": 1
  },
  {
    "question": "What is the debate between universal screening and case-finding for thyroid hormonal dysfunction during pregnancy?",
    "answer": "There is an ongoing debate regarding the effectiveness of universal screening versus case-finding approaches for detecting and treating thyroid hormonal dysfunction during pregnancy, with studies suggesting that universal screening may be more effective.",
    "is_verified": 1
  },
  {
    "question": "What are the adequate levothyroxine doses for treating hypothyroidism discovered during pregnancy?",
    "answer": "Adequate levothyroxine doses for treating hypothyroidism that is newly discovered during pregnancy have been established, ensuring that both maternal and fetal thyroid hormone levels are maintained within a healthy range.",
    "is_verified": 1
  },
  {
    "question": "What is subclinical hypothyroidism?",
    "answer": "Subclinical hypothyroidism is a mild form of hypothyroidism where patients have elevated thyroid-stimulating hormone (TSH) levels but normal levels of thyroid hormones (T3 and T4). It often presents without obvious symptoms and can be particularly relevant in certain populations, such as women with infertility issues.",
    "is_verified": 1
  },
  {
    "question": "What are the risks and benefits of treating subclinical hypothyroidism in infertile women?",
    "answer": "The treatment of subclinical hypothyroidism in infertile women is controversial. Potential benefits include improved fertility outcomes and reduced risk of miscarriage, while risks may involve unnecessary treatment and potential side effects from thyroid hormone replacement therapy. The decision to treat should be individualized based on patient history and clinical guidelines.",
    "is_verified": 1
  },
  {
    "question": "How does subclinical hypothyroidism affect obstetric and neonatal outcomes?",
    "answer": "Subclinical hypothyroidism in pregnant women has been associated with adverse obstetric outcomes, such as increased risk of miscarriage and complications during pregnancy. Neonatal outcomes may also be affected, with potential implications for the baby's growth and development. Monitoring and managing thyroid function during pregnancy is crucial for optimizing outcomes.",
    "is_verified": 1
  }
]
